{"schema_version":"secwatch.filing_event.v1","accession":"0001013762-21-000153","form_type":"8-K","ticker":"CRMD","cik":"0001410098","company_name":"CorMedix Inc.","filed_at":"2021-10-05T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.426918+00:00","generated_at":"2026-06-28T22:54:12.257453+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"CorMedix CEO and EVP retire; CFO Matthew David named interim CEO","bullets":["Khoso Baluch retired as CEO effective Oct 4, 2021, and resigned from the Board.","John Armstrong retired as EVP, Technical Operations, effective same date.","CFO Matthew David appointed interim CEO; search for permanent CEO initiated with executive search firm.","Both executives received severance per employment agreements; vested stock options exercisable up to 3 years post-retirement."],"urls":{"canonical":"https://secwatch.observer/filing/0001013762-21-000153","json":"https://secwatch.observer/filing/0001013762-21-000153.json","markdown":"https://secwatch.observer/filing/0001013762-21-000153.md","text":"https://secwatch.observer/filing/0001013762-21-000153.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1410098/000101376221000153/0001013762-21-000153-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1410098/000101376221000153/ea148384-8k_cormedix.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T22:54:12.257453+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"19418be9e4","claim":"Matthew David was appointed as Interim Chief Executive Officer at CorMedix Inc..","evidence_excerpt":"Matthew David, M.D., the Company’s current Chief Financial Officer, will serve as interim Chief Executive Officer, effective immediately, until a new Chief Executive Officer is appointed.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1410098/000101376221000153/0001013762-21-000153-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"1fa0c5ff58","claim":"John L. Armstrong, Jr. retired as Executive Vice President, Technical Operations at CorMedix Inc..","evidence_excerpt":"On October 4, 2021, the Company and John L. Armstrong, Jr. came to a mutual agreement pursuant to which Mr. Armstrong will retire from his position as the Company’s Executive Vice President, Technical Operations, effective October 4, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1410098/000101376221000153/0001013762-21-000153-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Executive Vice President, Technical Operations"}],"fact_type":"executive_change"},{"claim_id":"a76d888ef9","claim":"Khoso Baluch retired as Chief Executive Officer at CorMedix Inc..","evidence_excerpt":"On October 1, 2021, the Company and Khoso Baluch came to a mutual agreement pursuant to which Mr. Baluch will retire from his position as the Company’s Chief Executive Officer, effective October 4, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1410098/000101376221000153/0001013762-21-000153-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}